Madelia (Minn.) Health will close its only pharmacy May 28 due to rising costs. The location is the sole pharmacy in Lake Crystal, Minn., which has a population of 2,539, according to a May 12 Free Press report. The drugstore…
Pharmacy
GSK will acquire the liver disease drug efimosfermin from Boston Pharmaceuticals in a deal worth up to $2 billion, The Wall Street Journal reported May 14. The agreement includes a $1.2 billion upfront payment along with an additional $800 million…
As chain pharmacies shutter locations across the U.S., health systems and clinics are stepping in by investing in technology, opening new pharmacies and expanding services to ensure patients can access their medications, according to a May 13 report from the…
The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths. About 80,000 Ixchiq doses have been distributed globally, according to a May 12…
After entering bankruptcy for the second time in less than two years, Rite Aid plans to close a Maryland distribution center by early June. Rite Aid will lay off 363 workers at its Aberdeen, Md.-based Mid-Atlantic Distribution Center by June…
Advertisement
Independent pharmacists across the U.S. are stockpiling generic drugs as they brace for potential price hikes and supply disruptions following President Donald Trump’s threat to impose an additional tariff on pharmaceuticals, NPR and KFF Health News reported May 13. In…
Durham, N.C.-based Duke Health has partnered with Shields Health Solutions, a specialty pharmacy integrator, to expand its pharmacy operations. With the partnership, Duke Health aims to broaden access to medications for patients with complex chronic conditions by improving operations efficiency…
CMS proposed several changes for the third round of Medicare drug price negotiations, including the potential inclusion of some drugs under Medicare Part B, in a draft guidance published May 12. The guidance aims to increase program transparency, prioritize the…
President Donald Trump signed an executive order May 12 directing drugmakers to sell medicines in the U.S. at prices similar to those offered in other wealthy countries, or face penalties and enforcement actions. The move tasks HHS Secretary Robert F.…
In a 160-page bill introduced May 11, House Republicans proposed requiring pharmacy benefit managers to adhere to a transparent pass-through pricing model with states. If the bill — which aims to cut billions of dollars in Medicaid funds — passes,…